bupropion and nortriptyline

bupropion has been researched along with nortriptyline in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.02)	18.7374
1990's	10 (10.10)	18.2507
2000's	46 (46.46)	29.6817
2010's	35 (35.35)	24.3611
2020's	6 (6.06)	2.80

Authors

Authors	Studies
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Glen, RC; Lowe, R; Mitchell, JB	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Dalvie, D; Loi, CM; Smith, DA	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Burke, M; Preskorn, SH	1
Nierenberg, AA	1
Manji, HK; Potter, WZ	1
Patrick, GA; Rosenberger, W; Yutrzenka, GJ	1
de la Garza, R; Johanson, CE	1
Lai, CW; Othmer, E; Othmer, SC; Preskorn, SH	1
Apter, JT; Kushner, SF; Woolfolk, RL	1
Batey, SR; Holloman, LC; Johnston, JA; Kiev, A; Masco, HL; Wenger, TL	1
Biederman, J; Spencer, T; Steingard, R; Wilens, T	1
Benowitz, NL	1
Guadagno, G; Swartz, CM	1
Roose, SP; Spatz, E	1
Benowitz, NL; Dempsey, DA; Dolan-Mullen, P; Goldenberg, RL; Hughes, JR; Ogburn, PL; Oncken, C; Orleans, CT; Slotkin, TA; Whiteside, HP; Yaffe, S	1
Chavannes, NH; Huibers, MJ; van Schayck, CP; Wagena, EJ; Zeegers, MP	1
Weintraub, D	1
Coleman, T	1
Huibers, MJ; van Schayck, CP; Wagena, EJ	1
Golding, M; Hatsukami, DK; Jamerson, BD; Kotlyar, M	1
DeGraff, AC	1
Arroll, B	1
Hall, SM; Hartz, DT; Humfleet, GL; Maude-Griffin, R; Muñoz, RF; Reus, VI	1
Hatsukami, DK; Kotlyar, M	1
De Granda Orive, JI; Jiménez-Ruiz, C	1
Møller, AM; Tønnesen, H	1
Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM	1
Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A	1
Lichtenschopf, A; Zwick, H	1
McNee, W; Metcalfe, S; Moodie, P	1
Juniper, Z; Lee, M; McRobbie, H	1
Schroeder, SA	1
Huibers, MJ; Knipschild, PG; van Schayck, CP; Wagena, EJ; Wouters, EF	1
Metcalfe, S; Moodie, P	1
Foulds, J; Steinberg, MB; Williams, JM; Ziedonis, DM	1
Cesari, DH; Chatkin, JM; Fam, CF; Fritscher, CC; Haggsträm, FM; Sussenbach-Vaz, E	1
Corelli, RL; Hudmon, KS	1
Alpert, JE; Biggs, M; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Bensasi, S; Houck, PR; Lenze, EJ; Miller, MD; Mulsant, BH; Reynolds, CF; Stack, JA; Tew, JD; Whyte, EM	1
Hill, A	1
Duquet, N	1
Cofta-Woerpel, L; Wetter, DW; Wright, KL	1
Bullen, C; Fagerström, K; McRobbie, H; Whittaker, R	1
Frishman, WH	1
Bensasi, S; Dew, MA; Houck, PR; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Whyte, EM	1
Shoaib, M; Wing, VC	1
Coffay, AO	1
Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P	1
Campbell, LA; Kisely, S	1
Chavannes, NH; Frijling, BD; Goudswaard, AN; Kaper, J; van der Laan, JR; Wiersma, T; Wind, LA	1
Carrozzi, L; Pistelli, F; Viegi, G	1
Billups, SJ; Delate, T; Dugan, D	1
Bredesen, H; Lous, J	1
Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL	1
Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T	1
Berlin, I	1
Kaper, J; Severens, JL; Van Schayck, CP; Wagena, EJ; Wouters, EF	1
Roberts, DJ; Stellpflug, SJ	1
Bhat, A; Crain, D	1
Herman, AI; Sofuoglu, M	1
Allan, GM; Els, C; Ivers, N	1
Arrabal-Fernandes, FL; Bussacos, MA; Lombardi, EM; Prado, GF; Santos, Ude P; Terra-Filho, M	1
Postma, DS; Quaak, M; van Schayck, CP; van Schooten, FJ; Wagena, EJ	1
Belcon, AL	1
Lancaster, T; Stead, LF	1
Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C	1
Cahill, K; Lancaster, T; Perera, R; Stevens, S	1
Farinde, A	1
Cahill, K; Hartmann-Boyce, J; Hughes, JR; Lancaster, T; Stead, LF	1
Ebbert, JO; Elrashidi, MY	1
Blumenthal, SR; Castro, VM; Churchill, SE; Clements, CC; Erb, JL; Fava, M; Kohane, IS; Murphy, SN; Perlis, RH; Rosenfield, HR; Smoller, JW; Weilburg, JB	1
Alampay, MM; Flanagan, MC; Grammer, GG; Haigney, MC; Love, KM; Perito, RM	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F	1
Koilpillai, P; Lancaster, T; Stead, LF	1
Diaz, SH; Dunklee, L; Escalona, R; Fawcett, J; Romo, P; Rush, AJ; Vukelich, J; Yarns, BC	1
Andrade, AG; Bhugra, D; Carvalho, CFC; Castaldelli-Maia, JM; Frallonardo, FP; Gil, F; Guimarães-Pereira, BBS; Ismael, F; Loreto, AR; Richter, KP; Ventriglio, A	1
Chiamulera, C; West, RJ	1
Achenbach, C; Akanbi, MO; Bilaver, LA; Carroll, AJ; Hitsman, B; Jordan, N; McHugh, MC; Murphy, R; O'Dwyer, LC	1
Blumberger, DM; Brown, PJ; Cristancho, P; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Montes-Garcia, C; Mulsant, BH; Reynolds, CF; Rollman, BL; Roose, SP	1
Fanshawe, TR; Hartmann-Boyce, J; Hong, B; Livingstone-Banks, J; Wheat, H	1
Aveyard, P; Farley, A; Hollands, GJ; Lindson, N; Naughton, F	1
Hartmann-Boyce, J; Hong, B; Howes, S; Lindson, N; Livingstone-Banks, J	1
Blumberger, DM; Brown, PJ; Cristancho, P; Flint, AJ; Gebara, MA; Gettinger, TR; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Mulsant, BH; Nicol, GE; Oughli, HA; Pham, VT; Reynolds, CF; Rollman, BL; Roose, SP; Yang, L	1
Hajizadeh, A; Hartmann-Boyce, J; Howes, S; Klemperer, E; Lindson, N; Livingstone-Banks, J; Theodoulou, A	1
Deng, X; E, F; Guo, K; Li, X; Liang, S; Liu, W; Shang, X; Wang, Y; Wang, Z; Wu, Y; Yang, K; Zhou, L	1
Agrawal, S; Aveyard, P; Fanshawe, TR; Freeman, SC; Hajizadeh, A; Hartmann-Boyce, J; Lindson, N; Livingstone-Banks, J; Ordóñez-Mena, JM; Sutton, AJ; Theodoulou, A; Zhu, S	1
Ebell, MH	1

Reviews

36 review(s) available for bupropion and nortriptyline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Somatic therapy for major depressive disorder: selection of an antidepressant. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Depressive Disorder; Humans; Nortriptyline; Sertraline; Tranylcypromine; Trazodone	1992
Antidepressants, metabolites, and apparent drug resistance. Clinical neuropharmacology, 1990, Volume: 13 Suppl 1 Topics: Amoxapine; Antidepressive Agents; Bupropion; Drug Resistance; Humans; Nortriptyline; Propiophenones; Serotonin Antagonists; Trazodone	1990
Treatment of depression in patients with heart disease. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Comorbidity; Death, Sudden; Depressive Disorder; Double-Blind Method; Heart Block; Heart Diseases; Humans; Hypotension, Orthostatic; Myocardial Ischemia; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ventricular Fibrillation	1999
[Bupropion: an effective new aid for smoking cessation]. Nederlands tijdschrift voor geneeskunde, 2001, Jan-13, Volume: 145, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Humans; Nortriptyline; Smoking Cessation; Treatment Outcome	2001
Smoking cessation: integrating recent advances into clinical practice. Thorax, 2001, Volume: 56, Issue:7 Topics: Administration, Cutaneous; Antidepressive Agents; Bupropion; Ganglionic Stimulants; Health Education; Health Policy; Humans; Motivation; Nicotine; Nortriptyline; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; United Kingdom	2001
Effect of nonnicotine pharmacotherapy on smoking behavior. Pharmacotherapy, 2001, Volume: 21, Issue:12 Topics: Amphetamines; Bupropion; Clonidine; Doxepin; Humans; Naltrexone; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Smoking Cessation	2001
Managing nicotine addiction. Journal of dental education, 2002, Volume: 66, Issue:9 Topics: Administration, Inhalation; Adolescent; Adult; Antidepressive Agents, Tricyclic; Bupropion; Chewing Gum; Clonidine; Drug Combinations; Female; Humans; Logistic Models; Nicotine; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking; Sympatholytics; Tobacco Use Cessation; Tobacco Use Disorder; United States; United States Agency for Healthcare Research and Quality; Women's Health	2002
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. Expert opinion on drug safety, 2005, Volume: 4, Issue:2 Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines	2005
Non-nicotine pharmacotherapies for smoking cessation. Respiratory medicine, 2005, Volume: 99, Issue:10 Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Bupropion; Clonidine; Dopamine Uptake Inhibitors; Humans; Nortriptyline; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention	2005
Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug and alcohol review, 2006, Volume: 25, Issue:1 Topics: Adolescent; Adult; Bupropion; Clinical Trials as Topic; Clonidine; Drug Administration Routes; Female; Humans; Male; Nicotine; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking Cessation; Smoking Prevention; Treatment Outcome	2006
Pharmacologic interventions for smoking cessation. Critical care nursing clinics of North America, 2006, Volume: 18, Issue:1 Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline	2006
A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas. Texas medicine, 2006, Volume: 102, Issue:8 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Bupropion; Clonidine; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Health Care Costs; Humans; Nicotine; Nortriptyline; Smoking; Smoking Cessation; Texas; Tobacco Use Disorder; Treatment Outcome	2006
[Quit smoking is not just a matter or will]. Journal de pharmacie de Belgique, 2006, Volume: 61, Issue:4 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Tobacco Use Disorder	2006
Smoking cessation 3: multicomponent interventions. Behavioral medicine (Washington, D.C.), 2007,Winter, Volume: 32, Issue:4 Topics: Behavior Therapy; Bupropion; Clonidine; Combined Modality Therapy; Humans; Motivation; Nicotine; Nortriptyline; Psychotherapy, Brief; Smoking Cessation; Tobacco Use Disorder	2007
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neurotransmitter Uptake Inhibitors; Nicotinic Agonists; Nortriptyline; Quinoxalines; Referral and Consultation; Risk Reduction Behavior; Smoking; Smoking Cessation; Varenicline	2007
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline	2007
Use of smoking cessation therapies in individuals with psychiatric illness : an update for prescribers. CNS drugs, 2008, Volume: 22, Issue:4 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Drug Prescriptions; Humans; Mental Disorders; Nicotine; Nortriptyline; Smoking Cessation; Tobacco Use Disorder	2008
Pharmacotherapy for smoking cessation. Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Rimonabant; Smoking Cessation; Treatment Outcome; Varenicline	2008
Pharmacogenetics of smoking cessation therapy. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2010, Jan-05, Volume: 153B, Issue:1 Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline	2010
Therapeutic strategies to optimize the efficacy of nicotine replacement therapies. COPD, 2009, Volume: 6, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Humans; Nicotine; Nortriptyline; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder	2009
Comparison of available treatments for tobacco addiction. Current psychiatry reports, 2010, Volume: 12, Issue:5 Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline	2010
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. The Cochrane database of systematic reviews, 2012, Dec-12, Volume: 12 Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2012
[Smoking in COPD]. Archivos de bronconeumologia, 2011, Volume: 47 Suppl 8 Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline	2011
Pharmacological interventions for smoking cessation: an overview and network meta-analysis. The Cochrane database of systematic reviews, 2013, May-31, Issue:5 Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2013
Antidepressants for smoking cessation. The Cochrane database of systematic reviews, 2014, Jan-08, Issue:1 Topics: Anti-Anxiety Agents; Antidepressive Agents; Bupropion; Humans; Nortriptyline; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices	2014
Emerging drugs for the treatment of tobacco dependence: 2014 update. Expert opinion on emerging drugs, 2014, Volume: 19, Issue:2 Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2014
Interventions to increase adherence to medications for tobacco dependence. The Cochrane database of systematic reviews, 2015, Feb-23, Issue:2 Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Varenicline	2015
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. The Cochrane database of systematic reviews, 2015, Oct-12, Issue:10 Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2015
The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis. Addiction (Abingdon, England), 2019, Volume: 114, Issue:4 Topics: Adult; Behavior Therapy; Bupropion; Cigarette Smoking; Clonidine; Counseling; Developing Countries; Humans; Mobile Applications; Naltrexone; Nortriptyline; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline	2019
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. The Cochrane database of systematic reviews, 2019, 06-05, Volume: 6 Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2019
Interventions to increase adherence to medications for tobacco dependence. The Cochrane database of systematic reviews, 2019, 08-16, Volume: 8 Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder	2019
Antidepressants for smoking cessation. The Cochrane database of systematic reviews, 2020, 04-22, Volume: 4 Topics: Anti-Anxiety Agents; Antidepressive Agents; Bupropion; Humans; Nortriptyline; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2020
Antidepressants for smoking cessation. The Cochrane database of systematic reviews, 2023, 05-24, Volume: 5 Topics: Adolescent; Adult; Antidepressive Agents; Bupropion; Child; Humans; Nicotinic Agonists; Nortriptyline; Smoking Cessation; Varenicline; Young Adult	2023
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis. Addiction biology, 2023, Volume: 28, Issue:8 Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2023
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. The Cochrane database of systematic reviews, 2023, 09-12, Volume: 9 Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Female; Humans; Network Meta-Analysis; Nicotine; Nortriptyline; Pregnancy; Smoking Cessation; Varenicline	2023

Trials

14 trial(s) available for bupropion and nortriptyline

Article	Year
Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations. Journal of clinical psychopharmacology, 1984, Volume: 4, Issue:5 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Nortriptyline; Propiophenones; Random Allocation	1984
The cardiovascular effects of bupropion and nortriptyline in depressed outpatients. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:2 Topics: Adult; Aged; Blood Pressure; Bupropion; Cardiovascular System; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hypotension, Orthostatic; Male; Middle Aged; Nortriptyline	1994
Melancholia with onset during treatment with SSRIs. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1998, Volume: 10, Issue:4 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Comorbidity; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome	1998
Pharmacologic therapy for nicotine addiction. Chest, 2002, Volume: 122, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Double-Blind Method; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Disorder	2002
Psychological intervention and antidepressant treatment in smoking cessation. Archives of general psychiatry, 2002, Volume: 59, Issue:10 Topics: Adult; Antidepressive Agents; Behavior, Addictive; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Linear Models; Male; Nortriptyline; Placebos; Prevalence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome	2002
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Archives of internal medicine, 2005, Oct-24, Volume: 165, Issue:19 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nortriptyline; Patient Compliance; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Time Factors; Treatment Outcome	2005
A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. Pulmonary pharmacology & therapeutics, 2006, Volume: 19, Issue:3 Topics: Adrenergic Uptake Inhibitors; Bupropion; Counseling; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nortriptyline; Sleep Stages; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Xerostomia	2006
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STARD report. The American journal of psychiatry, 2006, Volume: 163, Issue:7* Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Over Studies; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Mianserin; Middle Aged; Mirtazapine; Nortriptyline; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2006
Impact of prior treatment exposure on response to antidepressant treatment in late life. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:11 Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Carbonate; Long-Term Care; Male; Nortriptyline; Paroxetine; Psychotherapy; Retreatment; Treatment Failure; Treatment Outcome	2006
The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. Addiction (Abingdon, England), 2009, Volume: 104, Issue:12 Topics: Adult; Aged; Antidepressive Agents; Bupropion; Confidence Intervals; Cost-Benefit Analysis; Cotinine; Female; Humans; Male; Middle Aged; Nortriptyline; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Smoking Cessation	2009
Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation. Addiction (Abingdon, England), 2012, Volume: 107, Issue:1 Topics: Alleles; Antidepressive Agents; Bupropion; Female; Genetic Variation; Genotype; Humans; Logistic Models; Male; Middle Aged; Netherlands; Nortriptyline; Placebos; Serotonin Plasma Membrane Transport Proteins; Smoking; Smoking Cessation; Treatment Outcome	2012
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2019, Volume: 27, Issue:10 Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Treatment-Resistant; Humans; Lithium Compounds; Multicenter Studies as Topic; Nortriptyline; Pragmatic Clinical Trials as Topic; Treatment Outcome	2019
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. The New England journal of medicine, 2023, Mar-23, Volume: 388, Issue:12 Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Humans; Lithium Compounds; Nortriptyline; Treatment Switching	2023

Other Studies

49 other study(ies) available for bupropion and nortriptyline

Article	Year
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7 Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:9 Topics: Antidepressive Agents; Attitude of Health Personnel; Bupropion; Decision Making; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Nortriptyline; Propiophenones; Psychiatry; Triiodothyronine	1991
Substitution of psychoactive drugs in pentobarbital-dependent rats. Drug and alcohol dependence, 1990, Volume: 26, Issue:1 Topics: Animals; Antidepressive Agents; Arousal; Body Weight; Brain; Bromazepam; Bupropion; Diazepam; Dose-Response Relationship, Drug; Male; Mazindol; Methaqualone; Motor Activity; Nortriptyline; Phenobarbital; Propiophenones; Psychotropic Drugs; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders	1990
Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3 Topics: Animals; Anti-Anxiety Agents; Appetite Depressants; Bupropion; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Macaca mulatta; Male; Morphine; Nortriptyline; Pentobarbital; Propiophenones; Substance-Related Disorders	1987
Bupropion/nortriptyline combination for refractory depression. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:4 Topics: Bupropion; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nortriptyline	1994
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:1 Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Humans; Male; Nortriptyline; Tourette Syndrome; Treatment Outcome	1993
Treating tobacco addiction--nicotine or no nicotine? The New England journal of medicine, 1997, Oct-23, Volume: 337, Issue:17 Topics: Antidepressive Agents; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder	1997
The use of pharmacotherapies for smoking cessation during pregnancy. Tobacco control, 2000, Volume: 9 Suppl 3 Topics: Antidepressive Agents; Bupropion; Education; Female; Health Promotion; Humans; Nortriptyline; Pregnancy; Prenatal Care; Smoking; Smoking Cessation; Treatment Outcome	2000
Nortriptyline toxicity secondary to interaction with bupropion sustained-release. Depression and anxiety, 2001, Volume: 13, Issue:1 Topics: Adrenergic Uptake Inhibitors; Aged; Aged, 80 and over; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Humans; Nortriptyline	2001
Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression. Thorax, 2001, Volume: 56, Issue:8 Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Humans; Lung Diseases, Obstructive; Nortriptyline; Smoking Cessation	2001
A cheap medication for smoking cessation. The New Zealand medical journal, 2002, Jun-21, Volume: 115, Issue:1156 Topics: Antidepressive Agents, Tricyclic; Bupropion; Drug Administration Schedule; Humans; Nortriptyline; Smoking Cessation	2002
Success rates for nortriptyline. Chest, 2003, Volume: 124, Issue:2 Topics: Antidepressive Agents, Tricyclic; Bupropion; Humans; Nortriptyline; Smoking Cessation; Treatment Outcome	2003
[Antidepressants for smoking cessation]. Ugeskrift for laeger, 2004, Oct-11, Volume: 166, Issue:42 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Evidence-Based Medicine; Humans; Nortriptyline; Smoking Cessation	2004
[COPD-rehabilitation]. Wiener medizinische Wochenschrift (1946), 2005, Volume: 155, Issue:5-6 Topics: Acupuncture Therapy; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aversive Therapy; Body Weight; Bupropion; Clinical Trials as Topic; Clonidine; Exercise; Humans; Hypnosis; Nortriptyline; Patient Education as Topic; Physical Endurance; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Smoking Cessation	2005
PHARMAC and tobacco control in New Zealand: two licensed funded options are already available. The New Zealand medical journal, 2005, Jun-24, Volume: 118, Issue:1217 Topics: Administration, Cutaneous; Bupropion; Cost-Benefit Analysis; Drug Industry; Evidence-Based Medicine; Humans; Licensure; New Zealand; Nicotine; Nortriptyline; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; United States	2005
What to do with a patient who smokes. JAMA, 2005, Jul-27, Volume: 294, Issue:4 Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines; Humans; Nicotine; Nortriptyline; Physician's Role; Smoking; Smoking Cessation; Tobacco Use Disorder; United States	2005
More on PHARMAC and tobacco control in New Zealand. The New Zealand medical journal, 2006, Jan-27, Volume: 119, Issue:1228 Topics: Bupropion; Cost-Benefit Analysis; Government Regulation; Humans; New Zealand; Nortriptyline; Smoking Cessation; Treatment Outcome	2006
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. The American journal of psychiatry, 2007, Volume: 164, Issue:6 Topics: Age Factors; Aged; Antidepressive Agents; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium Compounds; Male; Nortriptyline; Paroxetine; Psychotherapy; Secondary Prevention; Time Factors; Treatment Outcome	2007
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Psychopharmacology, 2007, Volume: 195, Issue:3 Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nortriptyline; Rats; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder	2007
Smoking cessation: tactics that make a big difference. The Journal of family practice, 2007, Volume: 56, Issue:10 Topics: Adult; Benzazepines; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; Nortriptyline; Patient Education as Topic; Quinoxalines; Smoking Cessation; Social Support; Varenicline	2007
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2008
[Summary of the practice guideline 'Smoking cessation' from the Dutch College of General Practitioners]. Nederlands tijdschrift voor geneeskunde, 2008, Jun-28, Volume: 152, Issue:26 Topics: Bupropion; Chronic Disease; Family Practice; Female; Humans; Male; Motivation; Netherlands; Nicotine; Nortriptyline; Practice Patterns, Physicians'; Smoking Cessation; Social Support; Societies, Medical	2008
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations. Pharmacoepidemiology and drug safety, 2009, Volume: 18, Issue:3 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors	2009
[Smoking cessation with special focus on primary health care]. Ugeskrift for laeger, 2009, Feb-23, Volume: 171, Issue:9 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascular Diseases; Counseling; Evidence-Based Medicine; Family Practice; Humans; Nicotine; Nortriptyline; Outcome Assessment, Health Care; Primary Health Care; Psychotherapy, Group; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention	2009
[Current and future medical drugs for smoking cessation]. Laryngo- rhino- otologie, 2009, Volume: 88, Issue:6 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline	2009
Which xenobiotic(s) could be responsible for the radiologic findings below? Answer: any proconvulsant xenobiotic, in this case tramadol, bupropion, and nortriptyline. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2010, Volume: 6, Issue:1 Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Back Pain; Bupropion; Drug Synergism; Female; Humans; Magnetic Resonance Imaging; Nortriptyline; Radiography; Seizures; Spinal Fractures; Thoracic Vertebrae; Tramadol	2010
Current treatment options in smoking cessation. Hospital practice (1995), 2010, Volume: 38, Issue:1 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline	2010
Pharmacotherapy for smoking. Canadian family physician Medecin de famille canadien, 2011, Volume: 57, Issue:1 Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline	2011
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success. Clinics (Sao Paulo, Brazil), 2011, Volume: 66, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Nortriptyline; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Young Adult	2011
Smoking cessation pharmacotherapy: a concise overview. Advance for NPs & PAs, 2011, Volume: 2, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2011
Antidepressants. Nursing, 2013, Volume: 43, Issue:9 Topics: Antidepressive Agents; Benzofurans; Bupropion; Drugs, Generic; Humans; Indoles; Nortriptyline; Piperazines; Sertraline; Vilazodone Hydrochloride	2013
An electronic health records study of long-term weight gain following antidepressant use. JAMA psychiatry, 2014, Volume: 71, Issue:8 Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Mass Index; Bupropion; Citalopram; Electronic Health Records; Female; Humans; Male; Middle Aged; New England; Nortriptyline; Prospective Studies; Weight Gain; Young Adult	2014
Transcranial magnetic stimulation as an antidepressant alternative in a patient with Brugada syndrome and recurrent syncope. Mayo Clinic proceedings, 2014, Volume: 89, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brugada Syndrome; Bupropion; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Electrocardiography; Humans; Male; Mianserin; Mirtazapine; NAV1.5 Voltage-Gated Sodium Channel; Nortriptyline; Syncope; Transcranial Magnetic Stimulation	2014
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression. The American journal of psychiatry, 2016, Feb-01, Volume: 173, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzothiazoles; Bipolar Disorder; Bupropion; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nortriptyline; Pramipexole; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride	2016
Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study. European psychiatry : the journal of the Association of European Psychiatrists, 2018, Volume: 52 Topics: Adult; Brazil; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Nortriptyline; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome	2018
What role does dopamine really play in tobacco addiction? Addiction (Abingdon, England), 2018, Volume: 113, Issue:8 Topics: Antidepressive Agents, Tricyclic; Bupropion; Dopamine; Humans; Nortriptyline; Nucleus Accumbens; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder	2018
Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults. American family physician, 2023, Volume: 108, Issue:3 Topics: Aged; Aripiprazole; Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Humans; Nortriptyline	2023